ReviewJournal of clinical medicine2024

Primary Cutaneous CD30-Positive Lymphoproliferative Disorders-Current Therapeutic Approaches with a Focus on Brentuximab Vedotin.

Tomasz Stein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.